Cancer treatment and monitoring methods using OX40 agonists
OX40 is a potent immune stimulating target. Provided herein are methods for the treatment of cancer patients using (3X40 agonists methods to predict clinical outcome of the treatment by correlation of the treatment and an increase in OX40-induced T cell proliferation.
PROVIDENCE HEALTH & SERVICES--OREGON (Renton, WA)
Curti, Brendan; Kovacsovics-Bankowski, Magdalena; Walker, Ed; Walker, Josh; and Weinberg, Andy, "Cancer treatment and monitoring methods using OX40 agonists" (2014). Technology Transfer - Patents. 33.